Tanda Ferguson
Nurse Practitioner · Yakima, WANPI 1093739997
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,005 of the $1,135 with a category attached, or 88.5%. It is spread thinly across 11 manufacturers, the largest accounting for just 20.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $531 and has fallen 73.7% since, to $140 in 2025. Among nurse practitioner clinicians in WA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 19 payments — averaging $59.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$227
- Intercept Pharmaceuticals, Inc.$210
- AstraZeneca$129
- Janssen Scientific Affairs, LLC$117
- Otsuka America Pharmaceutical, Inc.$116
- Neurocrine Biosciences, Inc.$103
- plus $233 from 5 others
What the payments were for
- Speaking & faculty fees$13011%
- Food & beverage$1,00589%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 5 | $227 |
| Intercept Pharmaceuticals, Inc. | 4 | $210 |
| AstraZeneca | 2 | $129 |
| Janssen Scientific Affairs, LLC | 1 | $117 |
| Otsuka America Pharmaceutical, Inc. | 1 | $116 |
| Neurocrine Biosciences, Inc. | 1 | $103 |
| Recordati_rare_diseases_inc. | 1 | $97 |
| AbbVie | 1 | $93 |
| Sanofi | 1 | $17 |
| Boehringer Ingelheim | 1 | $17 |
| Phathom Pharmaceuticals, Inc. | 1 | $8 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,135 in reported general payments places this provider in the 90th percentile of 2,466 nurse practitioner providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Mesalamine ErMesalamine | 12 | $3,243 |
| Famotidine | 59 | $941 |
| Omeprazole | 61 | $703 |
| Pantoprazole Sodium | 24 | $159 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Yakima
- Bonnie KultgenYakima$11K
- Olga VoloshinaSeattle$279K
- Sandra ChristensenSeattle$244K
- Felicia ForrestLynnwood$206K
- Amaris MurphyBellevue$146K
- Sonia GlennieSeattle$78K
- Megan WildesTacoma$72K
- Kate KennedyBellevue$63K
- Vicki HainesPasco$57K
- Jessica ArmitageSumner$46K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.